Brett Doliner1, Chuanhui Dong2, Susan H Blanton3, Hannah Gardener4, Mitchell S V Elkind5, Ralph L Sacco6, Ryan T Demmer7, Moise Desvarieux7, Tatjana Rundek8. 1. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida. Electronic address: bjd75@med.miami.edu. 2. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida. 3. Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida. 4. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida; Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami, Miami, Florida. 5. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York. 6. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida; Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida; Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami, Miami, Florida. 7. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. 8. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida; Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida.
Abstract
BACKGROUND: Apolipoprotein E (APOE) polymorphism has previously been associated with carotid intima-media thickness (cIMT) in predominantly Caucasian populations. We sought to test the strength of the relationship between APOE-ε4 carrier status and subclinical atherosclerosis in a tri-ethnic population with a large Hispanic representation. METHODS: We assessed the association between APOE polymorphism and cIMT and plaque burden among 1243 stroke-free individuals (mean age 69 years, 65% Hispanic, 18% black, 17% white) using a sequence of multivariable regression models. RESULTS: After adjusting for demographics, vascular risk factors and plasma low-density lipoprotein (LDL) levels, APOE-ε4 carrier status was positively associated with cIMT (mean difference, .013 mm; 95% confidence interval, .003-.023 mm). The APOE-ε4 association with cIMT appeared to be segment-specific with greater differences in IMT between APOE-ε4 carriers and noncarriers in the common carotid artery (CCA, .014 mm) and bifurcation (.017 mm) than in the internal carotid artery (ICA) IMT (.007 mm). This relationship was not modified by race-ethnicity. Presence of diabetes modified the ε4-cIMT relationship in CCA (P = .045) and ICA (P = .046). APOE-ε4 carrier status was not associated with plaque presence or plaque area. CONCLUSIONS: APOE-ε4 carriers had elevated cIMT independent of demographics and vascular risk factors including LDL levels. Diabetes was an effect modifier of the relationship between APOE-ε4 and IMT, such that ε4 carriers with diabetes had greater IMT in the CCA and ICA than those without diabetes. The APOE-IMT relationship was not modified by race-ethnicity.
BACKGROUND:Apolipoprotein E (APOE) polymorphism has previously been associated with carotid intima-media thickness (cIMT) in predominantly Caucasian populations. We sought to test the strength of the relationship between APOE-ε4 carrier status and subclinical atherosclerosis in a tri-ethnic population with a large Hispanic representation. METHODS: We assessed the association between APOE polymorphism and cIMT and plaque burden among 1243 stroke-free individuals (mean age 69 years, 65% Hispanic, 18% black, 17% white) using a sequence of multivariable regression models. RESULTS: After adjusting for demographics, vascular risk factors and plasma low-density lipoprotein (LDL) levels, APOE-ε4 carrier status was positively associated with cIMT (mean difference, .013 mm; 95% confidence interval, .003-.023 mm). The APOE-ε4 association with cIMT appeared to be segment-specific with greater differences in IMT between APOE-ε4 carriers and noncarriers in the common carotid artery (CCA, .014 mm) and bifurcation (.017 mm) than in the internal carotid artery (ICA) IMT (.007 mm). This relationship was not modified by race-ethnicity. Presence of diabetes modified the ε4-cIMT relationship in CCA (P = .045) and ICA (P = .046). APOE-ε4 carrier status was not associated with plaque presence or plaque area. CONCLUSIONS:APOE-ε4 carriers had elevated cIMT independent of demographics and vascular risk factors including LDL levels. Diabetes was an effect modifier of the relationship between APOE-ε4 and IMT, such that ε4 carriers with diabetes had greater IMT in the CCA and ICA than those without diabetes. The APOE-IMT relationship was not modified by race-ethnicity.
Authors: Matthias W Lorenz; Joseph F Polak; Maryam Kavousi; Ellisiv B Mathiesen; Henry Völzke; Tomi-Pekka Tuomainen; Dirk Sander; Matthieu Plichart; Alberico L Catapano; Christine M Robertson; Stefan Kiechl; Tatjana Rundek; Moïse Desvarieux; Lars Lind; Caroline Schmid; Pronabesh DasMahapatra; Lu Gao; Kathrin Ziegelbauer; Michiel L Bots; Simon G Thompson Journal: Lancet Date: 2012-04-27 Impact factor: 79.321
Authors: R L Sacco; B Boden-Albala; R Gan; X Chen; D E Kargman; S Shea; M C Paik; W A Hauser Journal: Am J Epidemiol Date: 1998-02-01 Impact factor: 4.897
Authors: A J Slooter; M L Bots; L M Havekes; A I del Sol; M Cruts; D E Grobbee; A Hofman; C Van Broeckhoven; J C Witteman; C M van Duijn Journal: Stroke Date: 2001-09 Impact factor: 7.914
Authors: Yi-Chu Liao; Hsiu-Fen Lin; Tatjana Rundek; Rong Cheng; Yuh-Cherng Guo; Ralph L Sacco; Suh-Hang Hank Juo Journal: Stroke Date: 2008-09-11 Impact factor: 7.914
Authors: John P Beilby; Clive C J Hunt; Lyle J Palmer; Caroline M L Chapman; Jodi P Burley; Brendan M McQuillan; Peter L Thompson; Joseph Hung Journal: Stroke Date: 2003-03-13 Impact factor: 7.914
Authors: Minghua Liu; Sanjeev Sariya; Farid Khasiyev; Giuseppe Tosto; Nicole D Dueker; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Tatjana Rundek; Mitchell S V Elkind; Jose Gutierrez Journal: J Neurol Sci Date: 2022-03-03 Impact factor: 4.553
Authors: Madeline A Czeck; Elise F Northrop; Nicholas G Evanoff; Donald R Dengel; Kyle D Rudser; Aaron S Kelly; Justin R Ryder Journal: J Pediatr Date: 2020-08-11 Impact factor: 4.406
Authors: Diana C Oviedo; Hector Lezcano; Ambar R Perez; Alcibiades E Villarreal; Maria B Carreira; Baltasar Isaza; Lavinia Wesley; Shantal A Grajales; Sara Fernandez; Ana Frank; Gabrielle B Britton Journal: AIMS Neurosci Date: 2018-06-16
Authors: Anitha Pitchika; Marcello Ricardo Paulista Markus; Sabine Schipf; Alexander Teumer; Sandra Van der Auwera; Matthias Nauck; Marcus Dörr; Stephan Felix; Hans-Jörgen Grabe; Henry Völzke; Till Ittermann Journal: Sci Rep Date: 2022-03-24 Impact factor: 4.379